Back to mobile site

Chiasma to Participate in Two September Investor Conferences

September 8, 2020 8:00 AM EDT

NEEDHAM, Mass., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial stage biopharmaceutical company utilizing its delivery platform technology to develop oral therapies to reduce the burden of chronic injections for people with rare diseases, today announced that management will be participating in two investor conferences in September.

Presentation details:

Event: HC Wainwright Virtual 22nd Annual Global Investment ConferenceFormat: Fireside chatDate: Monday, September 14, 2020Time: 1:00pm EDT

Event: Cantor Virtual Global Healthcare ConferenceFormat: Fireside chatDate: Wednesday, September 16, 2020Time: 11:20am EDT

A live audio webcast of both sessions will be available in the News and Investors section of Chiasma’s website at www.chiasma.com. A replay of both sessions will be available for 90 days. 

About ChiasmaChiasma is focused on developing and commercializing oral therapies to improve the lives of patients who face challenges associated with their existing treatments for rare and serious chronic diseases. Employing its Transient Permeability Enhancer (TPE®) technology platform, Chiasma seeks to develop oral medications that are currently available only as injections. On June 26, 2020, Chiasma received FDA approval of MYCAPSSA® for long-term maintenance therapy in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide. MYCAPSSA is the first and only oral somatostatin analog approved by the FDA. Chiasma is headquartered in Needham, MA with a wholly owned subsidiary in Israel. MYCAPSSA, TPE and CHIASMA are registered trademarks of Chiasma. For more information, please visit the company’s website at www.chiasma.com.

Investor Relations and Corporate Communications:Ashley RobinsonLifeSci Advisors, LLC 617-430-7577 [email protected]

Media Relations:Patrick BurseyLifeSci Communications646-876-4932[email protected]

Chiasma-Full-Color-Logo.png

Source: Chiasma


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Globe Newswire, Press Releases

Related Entities

Needham & Company, H.C. Wainwright, FDA